Achalasia management with per-oral endoscopic myotomy: A study of clinical success and complications at a tertiary center in Saudi Arabia.

IF 2
Abdulrahman Alfadda, Abdullah Alqaraawi, Aymen Almuhaidb, Khalid Al Kahtani, Faisal M Alyahya, Mohmmed Alzomia, Adnan Almahrouq, Musthafa C Peedikayil
{"title":"Achalasia management with per-oral endoscopic myotomy: A study of clinical success and complications at a tertiary center in Saudi Arabia.","authors":"Abdulrahman Alfadda, Abdullah Alqaraawi, Aymen Almuhaidb, Khalid Al Kahtani, Faisal M Alyahya, Mohmmed Alzomia, Adnan Almahrouq, Musthafa C Peedikayil","doi":"10.4103/sjg.sjg_256_25","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Per-oral endoscopic myotomy (POEM) has emerged as a minimally invasive treatment for achalasia, with growing global adoption. However, regional data from Saudi Arabia are scarce. This study aimed to evaluate the efficacy, safety, and long-term outcomes of POEM in a tertiary referral center in Riyadh.</p><p><strong>Methods: </strong>We conducted a retrospective cohort study of all consecutive patients with achalasia who underwent POEM at King Faisal Specialist Hospital and Research Centre between April 2017 and October 2023. Diagnosis was confirmed by high-resolution manometry and classified using the Chicago Classification v3.0 or v4.0. Clinical success was defined as an Eckardt score ≤3 at follow-up. Secondary outcomes included adverse events, gastroesophageal reflux disease (GERD), and need for further intervention.</p><p><strong>Results: </strong>A total of 105 patients (mean age 41.2 ± 13.9 years; 50.5% male) underwent POEM. The majority had type II achalasia (77.1%), followed by type III (12.4%) and type I (10.5%). Prior interventions were recorded in 25.7% of patients. Clinical success was achieved in 77.1%, with a significant reduction in mean Eckardt score (6.8 ± 2.3 to 1.8 ± 1.7; P < 0.001). The median follow-up was 1118 days. Patient satisfaction (≥80% symptom relief) was 69.5%. Complications occurred in 26.7%, predominantly gas-related events, with no procedure-related mortality. Major adverse events were rare (perforation 1.9%, reoperation 1.9%). Post-POEM GERD was confirmed in 24.4% of those tested with the Ph study, and 58.8% required proton pump inhibitor therapy at follow-up. Comparative analysis across time periods showed no significant difference in complication rates, although hospital stay was longer in the later cohort. Multivariable analysis did not identify independent predictors of clinical success.</p><p><strong>Conclusion: </strong>POEM is a safe and effective treatment for achalasia in Saudi Arabia, achieving substantial symptom relief with acceptable complication rates, consistent with international experience. The notable incidence of post-procedure GERD underscores the need for long-term reflux monitoring and management.</p>","PeriodicalId":520774,"journal":{"name":"Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2025-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/sjg.sjg_256_25","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Per-oral endoscopic myotomy (POEM) has emerged as a minimally invasive treatment for achalasia, with growing global adoption. However, regional data from Saudi Arabia are scarce. This study aimed to evaluate the efficacy, safety, and long-term outcomes of POEM in a tertiary referral center in Riyadh.

Methods: We conducted a retrospective cohort study of all consecutive patients with achalasia who underwent POEM at King Faisal Specialist Hospital and Research Centre between April 2017 and October 2023. Diagnosis was confirmed by high-resolution manometry and classified using the Chicago Classification v3.0 or v4.0. Clinical success was defined as an Eckardt score ≤3 at follow-up. Secondary outcomes included adverse events, gastroesophageal reflux disease (GERD), and need for further intervention.

Results: A total of 105 patients (mean age 41.2 ± 13.9 years; 50.5% male) underwent POEM. The majority had type II achalasia (77.1%), followed by type III (12.4%) and type I (10.5%). Prior interventions were recorded in 25.7% of patients. Clinical success was achieved in 77.1%, with a significant reduction in mean Eckardt score (6.8 ± 2.3 to 1.8 ± 1.7; P < 0.001). The median follow-up was 1118 days. Patient satisfaction (≥80% symptom relief) was 69.5%. Complications occurred in 26.7%, predominantly gas-related events, with no procedure-related mortality. Major adverse events were rare (perforation 1.9%, reoperation 1.9%). Post-POEM GERD was confirmed in 24.4% of those tested with the Ph study, and 58.8% required proton pump inhibitor therapy at follow-up. Comparative analysis across time periods showed no significant difference in complication rates, although hospital stay was longer in the later cohort. Multivariable analysis did not identify independent predictors of clinical success.

Conclusion: POEM is a safe and effective treatment for achalasia in Saudi Arabia, achieving substantial symptom relief with acceptable complication rates, consistent with international experience. The notable incidence of post-procedure GERD underscores the need for long-term reflux monitoring and management.

经口内窥镜肌切开术治疗贲门失弛缓症:沙特阿拉伯一家三级中心的临床成功和并发症研究。
背景:经口内窥镜下肌切开术(POEM)已成为一种治疗贲门失弛缓症的微创治疗方法,并在全球范围内得到越来越多的应用。然而,来自沙特阿拉伯的区域数据很少。本研究旨在评估利雅得一家三级转诊中心POEM的疗效、安全性和长期结果。方法:我们对2017年4月至2023年10月期间在费萨尔国王专科医院和研究中心接受POEM治疗的所有贲门失弛缓症患者进行了回顾性队列研究。通过高分辨率测压法确诊,并使用Chicago Classification v3.0或v4.0进行分类。临床成功定义为随访时Eckardt评分≤3。次要结局包括不良事件、胃食管反流病(GERD)和需要进一步干预。结果:105例患者(平均年龄41.2±13.9岁,男性50.5%)行POEM。多数为II型失弛缓症(77.1%),其次为III型(12.4%)和I型(10.5%)。25.7%的患者有干预记录。临床成功率77.1%,平均Eckardt评分显著降低(6.8±2.3至1.8±1.7;P < 0.001)。中位随访时间为1118天。患者满意度(症状缓解≥80%)为69.5%。26.7%发生并发症,主要是气体相关事件,无手术相关死亡。主要不良事件罕见(穿孔1.9%,再手术1.9%)。在Ph研究中,24.4%的患者证实了poem后胃食管反流,58.8%的患者在随访时需要质子泵抑制剂治疗。不同时期的比较分析显示,尽管住院时间较长,但并发症发生率无显著差异。多变量分析没有发现临床成功的独立预测因素。结论:POEM是沙特阿拉伯治疗贲门失弛缓症的一种安全有效的治疗方法,症状明显缓解,并发症发生率可接受,与国际经验一致。术后GERD的显著发生率强调了长期反流监测和管理的必要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信